When a health tech company closes a Series B round, the real work begins. Capital is secured, but visibility, credibility, and investor momentum still have to be earned. In one of the most scrutinized sectors in business, a generic PR push simply won't cut it. That's exactly the situation our client faced when they partnered with SlicedBrand, an award-winning global tech PR agency recognized by Business Insider as one of the top PR pros in the industry.

This case study breaks down how SlicedBrand designed and executed a precision PR strategy for a health tech innovator at the Series B stage, covering everything from media targeting and thought leadership to the press release campaign that drove real investor attention. If you're a health tech founder preparing for or emerging from a funding round, this is the playbook you need to understand.

About the Client

Our client is a B2B health technology platform operating at the intersection of clinical data and enterprise software, with a clear mission to improve care delivery efficiency for mid-sized and large health systems. By the time they engaged SlicedBrand, they had closed a substantial Series B round, had paying customers across multiple markets, and were preparing to expand into new geographies. The product had genuine clinical validation behind it, and early adoption metrics were strong. What they lacked was the kind of sustained, strategic media presence that would signal category leadership to the investment community, prospective enterprise buyers, and the broader health tech ecosystem.

They needed more than press releases. They needed a PR partner who understood the specific mechanics of health tech media, investor narrative-building, and multi-tiered outreach across clinical, trade, and business press simultaneously.

The Challenge: Why Series B Health Tech PR Is Different

Health tech companies operate in one of the most scrutinized environments in business. Claims are examined, data is questioned, and leadership credibility matters deeply. At the Series B stage, the stakes shift considerably. Early-stage PR centers on awareness and category education. By Series B, the objective moves to investor-facing credibility, defensible positioning, and long-term momentum that supports outcomes like late-stage funding, acquisition readiness, or a future IPO. A funding announcement alone is not a strategy. It is a moment, and without the right architecture around it, that moment fades quickly.

Our client faced three intertwined challenges when they came to us:

• Investor-grade visibility: They needed coverage in the outlets that institutional investors and analysts actually read, not just trade publications that spoke to existing industry insiders.
• Thought leadership positioning: Their leadership team had valuable perspectives on care delivery and digital health adoption, but those perspectives weren't reaching the right audiences in a consistent, credible way.
• Media complexity: Health tech coverage lives across three distinct media ecosystems — health and clinical publications, tech and startup press, and investor-facing business outlets. Operating across all three simultaneously requires specialist relationships and tailored messaging for each.

On top of these, the client was operating in a competitive segment where several well-funded rivals were actively pursuing the same tier-1 journalist relationships and the same editorial calendar moments. Standing out required more than a good story. It required the right story, told at the right time, to the right room.

The SlicedBrand Strategy

SlicedBrand built a multi-layered PR strategy designed to serve both immediate visibility goals (the funding announcement cycle) and longer-term positioning objectives (category leadership and investor confidence). The strategy was structured around four core pillars.

1. Media Tiering and Targeted Outreach

Not all media serves the same purpose, and one of the most common mistakes later-stage startups make is treating all coverage as equal. SlicedBrand built a clear media tier framework for the campaign from the outset. Tier 1 business and financial press (outlets read by institutional investors and analysts) was prioritized for the funding narrative and market leadership story. Tier 2 industry and health care trade media — publications like Healthcare IT News, MobiHealthNews, and MedTech Dive — served the credibility-building function with providers, partners, and potential enterprise customers. Tier 3 vertical and niche publications reinforced specific expertise and extended long-tail visibility across the health tech conversation.

Outreach to each tier was personalized rather than broadcast. SlicedBrand's team crafted individual pitches for target journalists, framing the client's story within the trends those reporters were actively covering: AI-driven clinical workflows, the pressure on health systems to reduce administrative burden, and the growing investor appetite for proven digital health platforms with real-world evidence behind them.

2. Funding Announcement Architecture

The Series B announcement was treated not as a single event but as a campaign with multiple touchpoints over several weeks. SlicedBrand developed a sequenced press release strategy, beginning with an embargo period to secure exclusives with high-authority outlets ahead of the public announcement date. This allowed the team to lock in tier-1 coverage that would go live the moment the round was officially public, creating immediate momentum rather than scrambling for attention after the fact.

Critically, the messaging was built around what the funding meant for the market, not just for the company. Rather than framing the announcement as internal growth news, SlicedBrand positioned it as a signal of where the health tech sector was heading, with the client as the defining example. The press release itself was distributed to targeted outlets rather than blasted through generic wire services, ensuring that every recipient was a relevant, high-authority media contact with genuine audience overlap.

3. Executive Thought Leadership and Interview Series

Sustainable PR momentum at Series B requires more than funding coverage. It requires a consistent executive voice in the media. SlicedBrand worked with the client's CEO and Chief Medical Officer to develop a thought leadership program that extended across bylined articles, podcast appearances, and interview placements in both business and clinical media. Topics were drawn directly from the issues dominating the health tech conversation: value-based care adoption, clinical workflow automation, and the integration challenges facing health systems trying to deploy enterprise software at scale.

Each interview was treated as a strategic narrative asset, not just a media moment. Key talking points were aligned with the messaging in the investor deck, ensuring consistency across every stakeholder touchpoint. Podcast placements extended the reach to audiences who don't consume traditional media, while bylined articles in industry publications built SEO-relevant backlinks and established domain authority alongside brand authority. For context on how this kind of approach fits into a broader tech PR framework, our AI PR services and Fintech PR services apply the same thought leadership architecture across adjacent sectors.

4. Newsjacking and Reactive Commentary

The health tech media cycle moves fast. Regulatory decisions, major clinical study releases, acquisition announcements, and policy debates all create windows for reactive commentary that can place a brand in front of journalists who are actively looking for expert voices. SlicedBrand monitored the health tech news environment continuously and identified several high-value newsjacking opportunities during the campaign period. When a high-profile study on EHR adoption friction made news, SlicedBrand moved quickly to position the client's CMO as a credible commentator with a specific, data-backed perspective. The resulting placement appeared in a national health technology publication and drove a measurable spike in inbound inquiries from enterprise health system prospects.

Results That Moved the Needle

Results are the measure of every PR campaign, and SlicedBrand delivered across every key metric. By the end of the engagement, the client had achieved the following:

• 30+ pieces of media coverage across the US, UK, and European markets, including placements in Tier 1 business and financial press
• Multiple high-authority backlinks from publications with Domain Authority scores above 80, directly strengthening the client's SEO performance and organic visibility
• Estimated audience reach of 1.5M+ across all placements, reaching investors, enterprise buyers, clinical leadership, and the broader health tech community
• 3 inbound investor inquiries directly attributable to media coverage from the funding announcement campaign
• Podcast and speaking placements at two leading digital health industry events, extending thought leadership reach beyond earned media
• Consistent executive visibility across a 12-week campaign window, with at least one substantive media placement per week throughout the engagement

Beyond the numbers, the campaign delivered something harder to quantify but equally important: a coherent, credible public narrative for the company that aligned investors, customers, and media around a single, compelling story. That narrative became the foundation for all subsequent communications as the company moved into its next growth phase.

Why Specialist Health Tech PR Matters at Series B

The health tech sector presents a communication challenge that generalist PR agencies are genuinely ill-equipped to handle. The audience is diverse — patients, providers, investors, regulators, and media — and each segment requires tailored messaging that balances clinical credibility with market ambition. PR that overpromises or overexposes can raise concerns rather than confidence, particularly with the institutional investors who are now evaluating operational maturity and leadership judgment rather than just product potential.

At the same time, the media landscape for health tech is unusually fragmented. Healthtech coverage lives across clinical publications, tech and startup press, and investor-facing business outlets, and an agency that only operates in one lane cannot serve the full visibility strategy a venture-backed company needs. SlicedBrand's global media relationships, built across years of technology PR work, span all three ecosystems. The same strategic storytelling capabilities that have delivered results for clients like Pluto TV and AirHelp translate directly into health tech, where the ability to translate complex technology into a clear, compelling narrative is the single most important skill a PR partner can bring.

For health tech companies exploring adjacent verticals or building toward a multi-sector narrative, SlicedBrand also brings deep expertise in GreenTech PR, Crypto PR, and LegalTech PR — areas that increasingly intersect with digital health as the sector matures and expands.

Ready to Grow Your Health Tech Brand?

A Series B round is a defining moment. The capital is there. The product is proven. What determines whether that momentum translates into the next stage of growth is the story you tell, the outlets you tell it in, and the consistency with which you show up in the spaces where investors, buyers, and partners are paying attention. SlicedBrand has helped some of the most innovative technology companies in the world navigate exactly these moments, delivering real coverage and results that exceed expectations.

Whether you're preparing for a funding announcement, building a thought leadership program from the ground up, or trying to break into tier-1 media for the first time, the approach is the same: strategic, targeted, and built around outcomes that actually matter to your business.